Prognostic markers for prediction of treatment response and/or survival of breast cell proliferative disorder patients

Details for Australian Patent Application No. 2010201017 (hide)

Owner Epigenomics AG

Inventors Adorjan, Peter; Lesche, Ralf; Maier, Sabine; Model, Fabian; Nimmrich, Inko; Rujan, Tamas; Foekens, John; Harbeck, Nadia; Konig, Thomas; Martens, John; Schmitt, Manfred; Dietrich, Dimo; Muller, Volkmar; Kluth, Antje; Schwope, Ina; Harmann, Oliver

Agent Pizzeys

Pub. Number AU-A-2010201017

Parent 2004237861

Filing date 16 March 2010

Wipo publication date 8 April 2010

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 35/00 (2006.01) Antineoplastic agents

C12Q 1/02 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

1 April 2010 Complete Application Filed

8 April 2010 Application Open to Public Inspection

  Published as AU-A-2010201017

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010201018-Improvements to pedestrian crossings

2010201016-Nucleic acids coding for adhesion factor of group B streptococcus, adhesion factors of group B streptococcus and further uses thereof